GlobalData's clinical trial report, Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hormone Refractory Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone Refractory Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hormone Refractory Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Reasons to buy